Royalty Pharma PLC (RPRX) vs Vertex Pharmaceuticals Incorporated (VRTX)

Royalty Pharma PLC and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $34.4B — 3.9× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 30.4× against 40.1×. Vertex Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 10.2% against 10.0%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 32.0%) and the higher return on invested capital (24.1% vs 5.28%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 14 and Royalty Pharma PLC on 8.